Both in Pharmaceuticals
Soligenix vs Alzamend Neuro
Over the past year SNGX returned −73.8% and ALZN returned −39.0%; their daily moves had a correlation of 0.04.
SNGX −73.8% ALZN −39.0%Growth of $1, one year, split-adjusted
| Metric | SNGX | ALZN |
|---|---|---|
| Price | $0.3508 | $1.53 |
| Market cap | $7.6M | $7.4M |
| Today | −1.49% | +4.79% |
| 1 month | −2.0% | +11.7% |
| 6 months | +6.0% | +39.1% |
| Year to date | −73.8% | −15.9% |
| 1 year | −76.1% | −39.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.8M | $7.6M |
| Dividend yield | — | — |
| Volatility (60d) | 40.6% | 83.1% |
| Short % of float | 0.8% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).